|
General Information
|
|
|
Product
|
GCN2 Peptide
|
|
Description
|
Antigenic Blocking Peptide eIF2alpha kinase Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 1600-1700 on human GCN2 protein.
|
|
Accession #
|
GenBank: CAB58363.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Immunoglobulin
|
IgG
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q9P2K8
|
|
Overview
|
Can phosphorylate alpha subunit of EIF2 and mediates translational control.
|
|
Molecular Function
|
ATP binding; Nucleotide binding
|
|
Subcellular Location
|
Cytosolic ribosome
|
|
Expression
|
Liver, brain.
|
|
Structure
|
Contains 2 protein kinase domains; Contains 1 RWD domain.
|
|
Alternative Nomenclature
|
Eif2ak4 antibody
Eukaryotic Translation Initiation Factor 2 alpha kinase 4 antibody
GCN2 antibody
GCN2 eIF2alpha kinase antibody
GCN2 like protein antibody
KIAA1338 antibody
MGCN2 antibody
|
| |
|
GCN2 Antibody
GCN2 Antibody FITC
GCN2 Antibody BIOTIN
GCN2 Positive Control
GCN2 Antibody
